140 related articles for article (PubMed ID: 37219517)
1. Phase separation is required for PML nuclear body biogenesis and function.
Wu W; Tan Y; Yin H; Jiang M; Jiang Y; Ma X; Yin T; Li Y; Zhang H; Cai X; Meng G
FASEB J; 2023 Jun; 37(6):e22986. PubMed ID: 37219517
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis of PML-RARA Oncoprotein Targeting by Arsenic Unravels a Cysteine Rheostat Controlling PML Body Assembly and Function.
Bercier P; Wang QQ; Zang N; Zhang J; Yang C; Maimaitiyiming Y; Abou-Ghali M; Berthier C; Wu C; Niwa-Kawakita M; Dirami T; Geoffroy MC; Ferhi O; Quentin S; Benhenda S; Ogra Y; Gueroui Z; Zhou C; Naranmandura H; de Thé H; Lallemand-Breitenbach V
Cancer Discov; 2023 Dec; 13(12):2548-2565. PubMed ID: 37655965
[TBL] [Abstract][Full Text] [Related]
3. On the Prevalence and Roles of Proteins Undergoing Liquid-Liquid Phase Separation in the Biogenesis of PML-Bodies.
Silonov SA; Mokin YI; Nedelyaev EM; Smirnov EY; Kuznetsova IM; Turoverov KK; Uversky VN; Fonin AV
Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136675
[TBL] [Abstract][Full Text] [Related]
4. New Evidence of the Importance of Weak Interactions in the Formation of PML-Bodies.
Fonin AV; Silonov SA; Fefilova AS; Stepanenko OV; Gavrilova AA; Petukhov AV; Romanovich AE; Modina AL; Zueva TS; Nedelyaev EM; Pleskach NM; Kuranova ML; Kuznetsova IM; Uversky VN; Turoverov KK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163537
[TBL] [Abstract][Full Text] [Related]
5. Activation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure.
Ablain J; Rice K; Soilihi H; de Reynies A; Minucci S; de Thé H
Nat Med; 2014 Feb; 20(2):167-74. PubMed ID: 24412926
[TBL] [Abstract][Full Text] [Related]
6. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
Patra U; Müller S
Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
[TBL] [Abstract][Full Text] [Related]
7. PML Nuclear bodies: the cancer connection and beyond.
Abou-Ghali M; Lallemand-Breitenbach V
Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
[TBL] [Abstract][Full Text] [Related]
8. The functional roles of PML nuclear bodies in genome maintenance.
Chang HR; Munkhjargal A; Kim MJ; Park SY; Jung E; Ryu JH; Yang Y; Lim JS; Kim Y
Mutat Res; 2018 May; 809():99-107. PubMed ID: 28521962
[TBL] [Abstract][Full Text] [Related]
9. Involvement of PML-I in reformation of PML nuclear bodies in acute promyelocytic leukemia cells by leptomycin B.
Wang C; Su L; Shao YM; Chen WZ; Bu N; Hao R; Ma LY; Hussain L; Lu XY; Wang QQ; Naranmandura H
Toxicol Appl Pharmacol; 2019 Dec; 384():114775. PubMed ID: 31669778
[TBL] [Abstract][Full Text] [Related]
10. PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders?
Brown NJ; Ramalho M; Pedersen EW; Moravcsik E; Solomon E; Grimwade D
Front Biosci (Landmark Ed); 2009 Jan; 14(5):1684-707. PubMed ID: 19273155
[TBL] [Abstract][Full Text] [Related]
11. Effects of arsenic on the topology and solubility of promyelocytic leukemia (PML)-nuclear bodies.
Hirano S; Udagawa O
PLoS One; 2022; 17(5):e0268835. PubMed ID: 35594310
[TBL] [Abstract][Full Text] [Related]
12. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
[TBL] [Abstract][Full Text] [Related]
13. Role of SUMO-1-modified PML in nuclear body formation.
Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of TRIM33 to cell-context specific PML nuclear bodies regulates nodal signaling in mESCs.
Sun H; Chen Y; Yan K; Shao Y; Zhang QC; Lin Y; Xi Q
EMBO J; 2023 Feb; 42(3):e112058. PubMed ID: 36524443
[TBL] [Abstract][Full Text] [Related]
15. Multimodal approach to characterize the tetrameric form of human PML-RBCC domain and ATO-mediated conformational changes.
Dubey S; Mishra N; Goswami N; Siddiqui MQ; Varma AK
Int J Biol Macromol; 2022 Dec; 223(Pt A):468-478. PubMed ID: 36356867
[TBL] [Abstract][Full Text] [Related]
16. PML nuclear body biogenesis and oligomerization-driven leukemogenesis.
Li Y; Ma X; Meng G
Blood Sci; 2020 Jan; 2(1):7-10. PubMed ID: 35399865
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes.
Udagawa O; Kato-Udagawa A; Hirano S
Biol Open; 2022 Jun; 11(6):. PubMed ID: 35579421
[TBL] [Abstract][Full Text] [Related]
19. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.
Lallemand-Breitenbach V; Zhu J; Puvion F; Koken M; Honoré N; Doubeikovsky A; Duprez E; Pandolfi PP; Puvion E; Freemont P; de Thé H
J Exp Med; 2001 Jun; 193(12):1361-71. PubMed ID: 11413191
[TBL] [Abstract][Full Text] [Related]
20. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML.
Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD
J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
